Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris B Quednow

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 9, 2022
Beyond the Brain: Behavioral Sociomics and the Future of PsychiatryBoris B Quednow
Progress in Brain Research|January 30, 2016
Human pharmacology for addiction medicine: From evidence to clinical recommendationsBoris B Quednow, Marcus Herdener
Frontiers in Pharmacology|February 7, 2018
How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence HypothesesStephan Schleim, Boris B Quednow
Physics of Life Reviews|October 25, 2025
What challenges remain after 25 years of the enhancement debate?: Comment on "To enhance or not to enhance: A debate about cognitive enhancement from a psychological and neuroscientific perspective" by Sandra Grinschgl, Manuel Ninaus, Guilherme Wood and Aljoscha C. NeubauerStephan Schleim, Boris B Quednow
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 8, 2025
Ketamine addiction in Europe: Any risks on the horizons?Francesco Bavato, Boris B Quednow
Neuroscience and Biobehavioral Reviews|June 12, 2022
The role of serotonin in declarative memory: A systematic review of animal and human researchRebecca Coray, Boris B Quednow
Brain : a Journal of Neurology|May 15, 2026
Reply: The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factorsBoris B Quednow, Rebecca C Coray
Der Nervenarzt|August 28, 2024
[Psychedelic and dissociative agents in psychiatry: challenges in the treatment]Johannes Jungwirth, Francesco Bavato, Boris B Quednow
Brain : a Journal of Neurology|August 24, 2023
The multifaceted role of neurofilament light chain protein: emerging opportunities in primary psychiatric conditionsFrancesco Bavato, Erich Seifritz, Boris B Quednow
Der Nervenarzt|September 4, 2024
Johannes Jungwirth, Francesco Bavato, Boris B Quednow
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|September 9, 2022
Beyond the Brain: Behavioral Sociomics and the Future of PsychiatryBoris B Quednow
Progress in Brain Research|January 30, 2016
Human pharmacology for addiction medicine: From evidence to clinical recommendationsBoris B Quednow, Marcus Herdener
Frontiers in Pharmacology|February 7, 2018
How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence HypothesesStephan Schleim, Boris B Quednow
Physics of Life Reviews|October 25, 2025
What challenges remain after 25 years of the enhancement debate?: Comment on "To enhance or not to enhance: A debate about cognitive enhancement from a psychological and neuroscientific perspective" by Sandra Grinschgl, Manuel Ninaus, Guilherme Wood and Aljoscha C. NeubauerStephan Schleim, Boris B Quednow
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 8, 2025
Ketamine addiction in Europe: Any risks on the horizons?Francesco Bavato, Boris B Quednow
Neuroscience and Biobehavioral Reviews|June 12, 2022
The role of serotonin in declarative memory: A systematic review of animal and human researchRebecca Coray, Boris B Quednow
Brain : a Journal of Neurology|May 15, 2026
Reply: The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factorsBoris B Quednow, Rebecca C Coray
Der Nervenarzt|August 28, 2024
[Psychedelic and dissociative agents in psychiatry: challenges in the treatment]Johannes Jungwirth, Francesco Bavato, Boris B Quednow
Brain : a Journal of Neurology|August 24, 2023
The multifaceted role of neurofilament light chain protein: emerging opportunities in primary psychiatric conditionsFrancesco Bavato, Erich Seifritz, Boris B Quednow
Der Nervenarzt|September 4, 2024
Johannes Jungwirth, Francesco Bavato, Boris B Quednow
Pageof 22